Refinement of crystal structure of 2-(2,3-dihydro-3-oxo-1 <b> <i>H</i> </b> -inden-1-ylidene)-1 <b> <i>H</i> </b> -indene-1,3(2 <b> <i>H</i> </b> )-dione C <sub>18</sub> H <sub>10</sub> O <sub>3</sub>
Abstract C 18 H 10 O 3 , monoclinic, P 2 1 / n (no. 14), a = 9.9981(2) Å, b = 9.3873(2) Å, c = 13.7621(3) Å, β = 102.841(2)°, V = 1,259.34(5) Å 3 , Z = 4, R gt ( F ) = 0.0463, wR ref ( F 2 ) = 0.1235, T = 293 K.
Authors
- X. Y. Shan (ORCID: https://orcid.org/0009-0009-0487-9474)
- Yuling Li (ORCID: https://orcid.org/0009-0007-9181-3224)
- Xiaozhuan Qin (ORCID: https://orcid.org/0009-0001-4730-5552)
- Zihao Li (ORCID: https://orcid.org/0009-0000-2939-2616)
- Lin Zhang (ORCID: https://orcid.org/0009-0009-8899-3898)
- Aochen Fu
Institutions
- Henan University of Technology (CN)
- Zhengzhou University (CN)
Publication Details
- Journal
- Zeitschrift für Kristallographie - New Crystal Structures
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1515/ncrs-2025-0163
- Primary Topic
- Pharmacological Receptor Mechanisms and Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Henan Normal University